UPDATE! - MLM Biologics, Inc. is now approved with both the VA system (through the Federal Supply Schedule) and US Military hospitals (through the Defense Acquisition Program Administration) beginning immediately.
MLM Biologics, Inc. is seeking distribution networks familiar with the Advance Wound Care market for their bio-ConneKt® Wound Matrix biologic scaffold. bio-ConneKt® Wound Matrix is a progressive wound treatment option capable of healing a wide range of acute, chronic and burn wounds. It is FDA-cleared, produced in an ISO-certified facility and has been shown to be a promising treatment option, especially for the full closure of chronic wounds. Designed to provide the body with what it needs to heal, it minimizes/eliminates repeat applications by compensating for several features of chronic wounds such as damaged cells, corrupt scaffolding, infection and other characteristics typical of the chronic wound environment. Matt Ellis, MD from Wound Therapy and Hyperbaric Services of Gainesville, Florida commented that “I have used bio-ConneKt Wound Matrix on a vast number of different indications, most where other more expensive options have failed. The bioavailability of b...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

